{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T17:17:55Z","timestamp":1774027075969,"version":"3.50.1"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T00:00:00Z","timestamp":1635120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Primary pulmonary hypertension (PPH) is a life-threatening disease associated with increased mortality. The urea cycle pathway plays a major role in PPH severity and treatment response. Little is known about the association of the blood urea nitrogen (BUN) and PPH prognosis.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Clinical data were extracted from the Medical Information Mart for Intensive Care III (MIMIC-III) database. Adult patients (\u226518 years) patients with primary pulmonary hypertension (PPH) in the database were enrolled. Spearman correlation was used to analyze the association of BUN with length of hospital and intensive care unit (ICU) stays. The chi-square test was used to analyze the association of BUN with mortality rate. Survival curves were estimated using the Kaplan-Meier method and compared by the log-rank test. Multivariable logistic regression was used to identify the BUN as an independent prognostic factor of mortality. Receiver operating characteristic (ROC) curves and the area under the curve (AUC) were used to analyze the sensitivity and specificity for mortality.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> In total, 263 patients who met the selection criteria were enrolled. BUN was significantly positively associated with length of hospital stay and ICU stay (hospital stay: \u03c1 = 0.282, ICU stay: \u03c1 = 0.276; all <jats:italic>P<\/jats:italic> &amp;lt; 0.001). Higher hospital, 90-day and 4-year mortality rates were observed in the higher BUN quartile of PPH patients (hospital: <jats:italic>P<\/jats:italic> = 0.002; 90-day: <jats:italic>P<\/jats:italic> = 0.025; 4-year: <jats:italic>P<\/jats:italic> &amp;lt; 0.001). The Kaplan-Meier survival curves showed that patients in higher BUN quartile tended to have lower 4-year survival (Q1:7.65%, Q2: 10.71%; Q3: 14.80%, Q4: 16.84%; <jats:italic>P<\/jats:italic> &amp;lt; 0.0001). Logistic regression analyses found a significant association of BUN and mortality (hospital: OR = 1.05, 95% CI = 1.02\u20131.08, <jats:italic>P<\/jats:italic> = 0.001; 90-day: OR = 1.02, 95% CI = 1.00\u20131.05, <jats:italic>P<\/jats:italic> = 0.027; 4-year: OR = 1.05, 95% CI = 1.02\u20131.08, <jats:italic>P<\/jats:italic> = 0.001). Results of ROC and AUC showed that the diagnostic performance of BUN for mortality was moderately good.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> BUN was positively correlated with the length of hospital stay and ICU stay of PPH patients. Higher BUN was associated with higher hospital, 90-day and 4-year mortality and lower 4-year survival of PPH patients. These findings indicate that BUN can be a novel potential prognostic predictor for PPH.<\/jats:p>","DOI":"10.3389\/fcvm.2021.724179","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T04:47:01Z","timestamp":1635137221000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Novel Prognostic Predictor for Primary Pulmonary Hypertension: Focus on Blood Urea Nitrogen"],"prefix":"10.3389","volume":"8","author":[{"given":"Bo","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangtao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolan","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanlu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuhui","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1016\/j.mayocp.2020.04.039","article-title":"Pulmonary hypertension: a brief guide for clinicians","volume":"95","author":"Mandras","year":"2020","journal-title":"Mayo Clin Proc."},{"key":"B2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijcard.2018.08.083","article-title":"Definition, clinical classification and initial diagnosis of pulmonary hypertension: updated recommendations from the Cologne Consensus Conference 2018","author":"Kovacs","year":"2018","journal-title":"Int J Cardiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Respir J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1164\/rccm.200412-1684OC","article-title":"Decreased exhaled nitric oxide in pulmonary arterial hypertension: response to bosentan therapy","volume":"172","author":"Girgis","year":"2005","journal-title":"Am J Respir Crit Care Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/pr.2017.143","article-title":"Polymorphisms in urea cycle enzyme genes are associated with persistent pulmonary hypertension of the newborn","volume":"83","author":"Kaluarachchi","year":"2018","journal-title":"Pediatr Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.mam.2004.09.002","article-title":"The basics about nitric oxide","volume":"26","author":"Bruckdorfer","year":"2005","journal-title":"Mol Aspects Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.jacc.2009.04.018","article-title":"Cellular and molecular basis of pulmonary arterial hypertension","volume":"54","author":"Morrell","year":"2009","journal-title":"J Am Coll Cardiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/antiox6030054","article-title":"Reactive oxygen and nitrogen species in the development of pulmonary hypertension","volume":"6","author":"Fulton","year":"2017","journal-title":"Antioxidants."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1016\/j.freeradbiomed.2012.02.041","article-title":"Reactive oxygen and nitrogen species in pulmonary hypertension","volume":"52","author":"Tabima","year":"2012","journal-title":"Free Radic Biol Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00210-008-0286-7","article-title":"Arginase and pulmonary diseases","volume":"378","author":"Maarsingh","year":"2008","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12931-018-0800-5","article-title":"Metabolic reprogramming of the urea cycle pathway in experimental pulmonary arterial hypertension rats induced by monocrotaline","volume":"19","author":"Zheng","year":"2018","journal-title":"Respir Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"160035","DOI":"10.1038\/sdata.2016.35","article-title":"MIMIC-III, a freely accessible critical care database","volume":"3","author":"Johnson","year":"2016","journal-title":"Sci Data."},{"key":"B13","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/S2213-2600(15)00543-3","article-title":"A global view of pulmonary hypertension","volume":"4","author":"Hoeper","year":"2016","journal-title":"Lancet Respir Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1097\/HCO.0000000000000791","article-title":"Pulmonary hypertension associated with left-sided heart failure","volume":"35","author":"Adler","year":"2020","journal-title":"Curr Opin Cardiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"228","DOI":"10.4081\/reumatismo.2020.1310","article-title":"Pulmonary arterial hypertension: guidelines and unmet clinical needs","volume":"72","author":"Giuggioli","year":"2021","journal-title":"Reumatismo."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2045894020935291","DOI":"10.1177\/2045894020935291","article-title":"Long-term outcomes in pulmonary arterial hypertension by functional class: a meta-analysis of randomized controlled trials and observational registries","volume":"10","author":"Kim","year":"2020","journal-title":"Pulm Circ."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.2217\/bmm.14.69","article-title":"Novel serum biomarkers in pulmonary arterial hypertension","volume":"8","author":"McGlinchey","year":"2014","journal-title":"Biomark Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"200009","DOI":"10.1183\/16000617.0009-2020","article-title":"BNP\/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?","volume":"29","author":"Lewis","year":"2020","journal-title":"Eur Respir Rev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.4103\/2045-8932.109917","article-title":"Pim-1: A new biomarker in pulmonary arterial hypertension","volume":"3","author":"Renard","year":"2013","journal-title":"Pulm Circ."},{"key":"B20","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1161\/CIRCRESAHA.114.302221","article-title":"Evidence for the involvement of type I interferon in pulmonary arterial hypertension","volume":"114","author":"George","year":"2014","journal-title":"Circ Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1136\/hrt.2011.224857","article-title":"Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension","volume":"97","author":"Rhodes","year":"2011","journal-title":"Heart."},{"key":"B22","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1111\/bcp.12282","article-title":"Urinary kidney biomarkers for early detection of nephrotoxicity in clinical drug development","volume":"77","author":"van Meer","year":"2014","journal-title":"Br J Clin Pharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4103\/ijn.IJN_407_17","article-title":"Pulmonary hypertension in various stages of chronic kidney disease in Indian patients","volume":"29","author":"Mehta","year":"2019","journal-title":"Indian J Nephrol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"570874","DOI":"10.3389\/fmed.2020.570874","article-title":"The prevalence of pulmonary hypertension among maintenance dialysis patients with ESRD and its associated factors: a retrospective study","volume":"7","author":"Zhang","year":"2020","journal-title":"Front Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.amjmed.2003.11.014","article-title":"Elevated blood urea nitrogen level as a predictor of mortality in patients admitted for decompensated heart failure","volume":"116","author":"Aronson","year":"2004","journal-title":"Am J Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/mgg3.58","article-title":"Mutations of NOTCH3 in childhood pulmonary arterial hypertension","volume":"2","author":"Chida","year":"2014","journal-title":"Mol Genet Genomic Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.healun.2014.01.853","article-title":"Endothelin antagonism and uric acid levels in pulmonary arterial hypertension: clinical associations","volume":"33","author":"Dhaun","year":"2014","journal-title":"J Heart Lung Transplant."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1096\/fj.04-2317fje","article-title":"Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension","volume":"18","author":"Xu","year":"2004","journal-title":"FASEB J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1056\/NEJM200106143442404","article-title":"Neonatal pulmonary hypertension\u2013urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function","volume":"344","author":"Pearson","year":"2001","journal-title":"N Engl J Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e439","DOI":"10.1111\/apa.12717","article-title":"Arginase I gene single-nucleotide polymorphism is associated with decreased risk of pulmonary hypertension in bronchopulmonary dysplasia","volume":"103","author":"Trittmann","year":"2014","journal-title":"Acta Paediatr."},{"key":"B31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000244091","article-title":"Arginine deficiency accompanies persistent pulmonary hypertension of the newborn","volume":"66","author":"Vosatka","year":"1994","journal-title":"Biol Neonate."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.724179\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T04:47:04Z","timestamp":1635137224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.724179\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,25]]},"references-count":31,"alternative-id":["10.3389\/fcvm.2021.724179"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.724179","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,25]]},"article-number":"724179"}}